Physician profile
Claire Edwards
NPI 1134364599
$1,048.13
in general payments reported to CMS, 2019-2025
11 companies · $23.03 in 2025
The $23.03 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.21 · 2020: $41.83 · 2021: $17.74 · 2023: $847 · 2024: $80.18 · 2025: $23.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $770 · Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $770.00 |
| Food and Beverage | $180.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $770.00 | 2023 | Natrelle Saline-Filled Breast Implants |
| Myriad Genetic Laboratories, INC. | $79.18 | 2023-2024 | Myrisk |
| Novartis Pharmaceuticals Corporation | $28.25 | 2024 | |
| Eisai INC. | $26.05 | 2024 | |
| Focal Therapeutics, INC. | $25.31 | 2019 | |
| Integra Lifesciences Corporation | $25.14 | 2020 | |
| Seagen INC. | $23.84 | 2023 | Tivdak |
| Azurity Pharmaceuticals, INC. | $23.03 | 2025 | Vivimusta |
| Kci USA, INC. | $17.74 | 2021 | |
| Allergan, INC. | $16.69 | 2020 | |
| Tactile Systems Technology INC | $12.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claire Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.